The trademark application OPAZZUS was filed by Regeneron Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on April 21, 2020, and it was registered by office on July 30, 2020 without any oppositions.
The application was filed in English (German was selected as the second language).